MedPath

泰州迈博太科药业有限公司

Ownership
-
Established
2015-02-04
Employees
-
Market Cap
-
Website
www.mabpharm.net

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Cetuximab Beta Injection

Product Name
恩立妥
Approval Number
国药准字S20240025
Approval Date
Jun 18, 2024
NMPA

Omalizumab alfa for Injection

Product Name
注射用奥马珠单抗α
Approval Number
国药准字S20230030
Approval Date
May 19, 2023
NMPA

Omalizumab alfa for Injection

Product Name
注射用奥马珠单抗α
Approval Number
国药准字S20230031
Approval Date
May 19, 2023
NMPA

Infliximab for Injection

Product Name
类停
Approval Number
国药准字S20210025
Approval Date
Jul 12, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.